Preclinical Imaging of Therapy Response Using Metabolic and Apoptosis Molecular Imaging

[1]  F. Mottaghy,et al.  Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  F. Mottaghy,et al.  Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo. , 2010, Bioorganic & medicinal chemistry.

[3]  F. Mottaghy,et al.  Molecular imaging of cell death. , 2009, Methods.

[4]  S. Pileri,et al.  Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma , 2009 .

[5]  J. Talbot,et al.  Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  M. Verheij.  Clinical biomarkers and imaging for radiotherapy-induced cell death , 2008, Cancer and Metastasis Reviews.

[7]  M. Verheij,et al.  Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. Van de Wiele,et al.  99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy. , 2007, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.

[9]  J. Nuyts,et al.  Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  L. Mortelmans,et al.  Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by Integrated International Workshop Criteria , 2007, Leukemia & lymphoma.

[11]  K. Brindle,et al.  Assessing responses to cancer therapy using molecular imaging. , 2006, Biochimica et biophysica acta.

[12]  G. Slegers,et al.  Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  B. Cheson,et al.  Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.

[14]  N. Sterin-Speziale,et al.  Compartmental study of rat renal phospholipid metabolism , 2006, Lipids.

[15]  M. Defrise,et al.  Single and multipinhole collimator design evaluation method for small animal SPECT , 2005, IEEE Nuclear Science Symposium Conference Record, 2005.

[16]  Chun Li,et al.  The Imaging of Apoptosis with the Radiolabeled annexin V: Optimal Timing for Clinical Feasibility , 2004, Technology in cancer research & treatment.

[17]  F. Blankenberg,et al.  Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. , 2004, Molecular imaging.

[18]  Patrick Dupont,et al.  [18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction? , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  P. Dupont,et al.  Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Roland Hustinx,et al.  Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  B. Joseph,et al.  Role of Apoptosis in the Response of Lung Carcinomas to Anti‐Cancer Treatment , 2000, Annals of the New York Academy of Sciences.

[22]  W. Zheng,et al.  Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. , 2000, Gynecologic oncology.

[23]  O. Fromigué,et al.  Bisphosphonates Induce Breast Cancer Cell Death In Vitro , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[25]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[26]  M. Ogura,et al.  Randomized Comparison of Mobilization Kinetics of Circulating CD34+ Cells Between Biweekly CHOP and Dose-Escalated CHOP with the Prophylactic Use of Lenograstim (Glycosylated rHuG-CSF) in Aggressive Non-Hodgkin's Lymphoma , 2000, Leukemia & lymphoma.

[27]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[28]  K.,et al.  Eradication of Minimal Disease in Severe Combined Immunodeficient Mice With Disseminated Daudi Lymphoma Using Chemotherapy and an Immunotoxin Cocktail , 2000 .

[29]  John L. Humm,et al.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[30]  M. Flentje,et al.  Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. , 1999, Acta oncologica.

[31]  J. Matthews,et al.  Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  J. Uhr,et al.  Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid mice , 1990, International journal of cancer.

[34]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[35]  F. Schabel,et al.  Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. , 1975, Cancer research.